In recent years, reports have indicated that FLT3LG can facilitate the proliferation of immune cells, impede tumor growth either directly or indirectly, and augment the effectiveness of anti-PD-1 therapy in solid tumors [30–33]. This evidence concerns the gene FLT3LG and neoplasm.